Overview

Human Rotavirus Vaccine Market is estimated to register a CAGR of over 11.2% during the forecast period 2022 to 2028.

Rotavirus is a diarrhea-causing virus that is very contagious. Prior to the development of a vaccine, the majority of kids had at least one infection with the virus by the time they turned five. Despite how nasty rotavirus infections are, they are frequently treated at home with additional fluids to prevent dehydration. In the hospital, patients with severe dehydration may need to receive fluids intravenously (via a vein). Maintaining proper hygiene is crucial, including routine hand washing. On the other hand, immunisation is the most effective defence against rotavirus infection. Rotavirus infection typically develops two days after virus contact. The first symptoms are fever and vomiting, which are followed by watery diarrhoea that lasts three to seven days. Additionally, the illness may result in stomach ache. A healthy adult may experience no symptoms at all or very minor ones as a result of rotavirus infection. Up to ten days before to the onset of symptoms as well as after they have subsided, rotavirus can be found in a person's face. During this time, the virus spreads swiftly through hand-to-mouth contact even if the infected person is asymptomatic. Children under the age of five are most frequently affected by severe diarrhoea from rotavirus infections, which can be prevented by the rotavirus vaccine. Immunizations aid in the prevention of severe diarrhoea in both developed and poor nations. Vaccines reduce the likelihood that young children will die from diarrhoea. Infant vaccination reduces disease rates among the elderly and those who have never had any vaccinations. The rotavirus vaccine should be included in national routine vaccination programmes, particularly in regions where the disease is prevalent, the World Health Organization (WHO) urges.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Human Rotavirus Vaccine Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Human Rotavirus Vaccine Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Human Rotavirus Vaccine Market:
• Biological E
• GlaxoSmithKline plc
• Merck & Co.
• Bharat Biotech
• Lanzhou Institute of Biologicals Products Co. Ltd
• QIMR Berghofer Medical Research Institute
• BIOVIRx Inc
• Rixensart
• Emergent BioSolutions
• Astellas Pharma
(Note: The list of the major players will be updated with the latest market scenario and trends)

Human Rotavirus Vaccine Market Segmentation:
By Type
• Rotarix
• Rotavac
• RotaTeq
• Others
By End User
• Hospitals
• Clinics
• Academic & Research Lab
• Others
By Region
• North America
Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Human Rotavirus Vaccine Market By Type, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics